Molecular Diagnostics
Genome-Wide cfDNA Analysis Detects Therapy Response in B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common, aggressive type of non-Hodgkin lymphoma. Although 50% to 60% of individuals achieve cure with chemoimmunotherapy, outcomes are poor for relapsed/refractory disease. More...10 Nov 2021
Endotoxemia Genetic Profile Reveals an Association with Thromboembolism and Stroke
Microorganisms are part of the human body, and bacteria or their components often end up in the circulation. One such bacterial component is lipopolysaccharide (LPS), which is a toxin. High concentrations of LPS in the blood cause sepsis. Low LPS levels, known as endotoxemia, cause low-grade inflammation. More...09 Nov 2021
New Biomarker Improves Definition of Medulloblastoma Risk
An immunohistochemistry marker has been identified as being able to improve risk stratification of medulloblastoma, the most common form of pediatric brain tumor, using a technique that is within the capabilities of most clinical laboratories. More...08 Nov 2021
Seegene Launches STARlet-AIOS All-in-One System that Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
Seegene, Inc. (Seoul, Korea) has launched its fully automated STARlet-AIOS: All-in-One System (AIOS) that addresses the needs of small, mid-sized, and large hospitals and COVID-19 laboratories. More...03 Nov 2021
A Liquid Biopsy Approach for Predicting Likely Relapse Following Treatment of Medulloblastoma in Children
A liquid biopsy technique that determines the level of cell-free DNA in cerebrospinal fluid (CSF) can be used to detect measurable residual disease (MRD) in children being treated for the malignant brain tumor medulloblastoma. More...02 Nov 2021
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Hemodynamic System Monitor
OptoMonitor
New
Human Estradiol Assay
Human Estradiol CLIA Kit
In Other News
Gene Expression Test Improves Idiopathic Pulmonary Fibrosis Diagnosis
Cyclic Adenosine Monophosphate (cAMP) May Be a Diagnostic Biomarker for Chronic Respiratory Diseases
Bio-Rad Launches New CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics
New Method Promises Rapid Isolation of Biomarker-Rich Extracellular Vesicles
AI-Based Technology Identifies Genetic Causes of Serious Diseases
Meridian Launches Innovative Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples
Next Generation Sequencing (NGS)-Based Breast Cancer Monitoring Test Could Aid Timely Treatment Decisions
Blood Test Combines Cutting-Edge Genomics and AI to Identify Persistent or Recurrent Cancer
Revolution in Rapid Testing: A New Generation of Programmable Lateral Flow Assays
Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk
Low Anti-SARS-CoV-2 S Antibody Levels Predict Increased Mortality
Biohit’s Innovative GastroPanel Quick Test Receives CE Mark
Fecal Immunochemical Tubes Sourced to Analyze Gut Microbiome for CRC
First-of-Its-Kind Testing Device Allows For Rapid Detection of Bacteria That Identify Risk for Preterm Birth
Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis
Unique Gene Detects Mycobacterium Tuberculosis in Clinical Sputum
Whole-Genome Sequencing Applied to Acutely Ill Infants
High Cell-Free DNA Integrity Is a Biomarker for Poor Breast Cancer Survival
Elevated Circulating Fatty Acid Synthase Is a Diagnostic Biomarker for Peripheral Artery Disease
Meridian Launches New Air-Dryable qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples
ALPK3 Truncating Variants Cause Autosomal Dominant Hypertrophic Cardiomyopathy
PCR Assay Detects and Differentiates Coccidioides Species
Next-Generation Multiomics Blood-Based Test for Pancreatic Cancer Could Become Powerful Tool for Early Diagnosis and Treatment
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.